Savara, Inc. (SVRA)
4.81
-0.24
(-4.66%)
USD |
NASDAQ |
Oct 02, 16:00
4.815
0.00 (0.00%)
After-Hours: 20:00
Savara Market Cap : 987.97M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 987.97M |
| October 01, 2026 | 1.036B |
| September 30, 2026 | 1.060B |
| September 29, 2026 | 1.043B |
| September 28, 2026 | 1.041B |
| September 25, 2026 | 1.027B |
| September 24, 2026 | 1.041B |
| September 23, 2026 | 1.027B |
| September 22, 2026 | 1.089B |
| September 21, 2026 | 1.119B |
| September 18, 2026 | 1.103B |
| September 17, 2026 | 1.113B |
| September 16, 2026 | 1.054B |
| September 15, 2026 | 1.080B |
| September 14, 2026 | 1.097B |
| September 11, 2026 | 1.089B |
| September 10, 2026 | 1.093B |
| September 09, 2026 | 1.112B |
| September 08, 2026 | 1.136B |
| September 04, 2026 | 1.103B |
| September 03, 2026 | 1.103B |
| September 02, 2026 | 1.121B |
| September 01, 2026 | 1.099B |
| August 31, 2026 | 1.107B |
| August 28, 2026 | 1.080B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.128B |
| August 26, 2026 | 1.152B |
| August 25, 2026 | 1.150B |
| August 24, 2026 | 1.142B |
| August 21, 2026 | 1.148B |
| August 20, 2026 | 1.128B |
| August 19, 2026 | 1.146B |
| August 18, 2026 | 1.103B |
| August 17, 2026 | 1.103B |
| August 14, 2026 | 1.105B |
| August 13, 2026 | 1.082B |
| August 12, 2026 | 1.171B |
| August 11, 2026 | 1.144B |
| August 10, 2026 | 1.177B |
| August 07, 2026 | 1.197B |
| August 06, 2026 | 1.189B |
| August 05, 2026 | 1.129B |
| August 04, 2026 | 1.109B |
| August 03, 2026 | 1.092B |
| July 31, 2026 | 1.119B |
| July 30, 2026 | 1.135B |
| July 29, 2026 | 1.082B |
| July 28, 2026 | 1.092B |
| July 27, 2026 | 1.113B |
| July 24, 2026 | 1.129B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 179.62B |
| Insmed, Inc. | 24.26B |
| United Therapeutics Corp. | 23.12B |
| Vertex Pharmaceuticals, Inc. | 127.87B |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
Market Cap Related Metrics
| PEG Ratio | -0.6729 |
| Price to Book Value | 6.877 |
| Price | 4.81 |
| Earnings Yield | -11.99% |
| PEGY Ratio | -0.6729 |